migraine treatment

Showing 1 posts of 1 posts found.

NICE backs atogepant for acute migraine treatment

June 12, 2026
NICE, atogepant, migraine treatment

NICE has issued Final Draft Guidance recommending AbbVie’s AQUIPTA (atogepant) as an option for the acute treatment of migraine, with …

The Gateway to Local Adoption Series

Latest content